Projects per year
Fingerprint
Dive into the research topics where Elisabeth M. Paietta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 2 Finished
-
ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
Levine, R., Melnick, A. M., Melnick, A. M., Paietta, E. M., Rose, S. A., Rose, S. A., Rose, S. A. & Paietta, E. M.
4/14/14 → 8/31/19
Project: Research project
-
ECOG-ACRIN INTEGRATED LEUKEMIA TRANSLATIONAL RESEARCH CENTER
Paietta, E. M. & Paietta, E. M.
4/14/14 → 8/31/19
Project: Research project
Publications
-
Chemotherapy induces senescence-like resilient cells capable of initiating aml recurrence
Duy, C., Li, M., Teater, M., Meydan, C., Garrett-Bakelman, F. E., Lee, T. C., Chin, C. R., Durmaz, C., Kawabata, K. C., Dhimolea, E., Mitsiades, C. S., Doehner, H., D’andrea, R. J., Becker, M. W., Paietta, E. M., Mason, C. E., Carroll, M. & Melnick, A. M., 2021, In: Cancer discovery. 11, 6, p. 1542-1561 20 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia
Gocho, Y., Liu, J., Hu, J., Yang, W., Dharia, N. V., Zhang, J., Shi, H., Du, G., John, A., Lin, T. N., Hunt, J., Huang, X., Ju, B., Rowland, L., Shi, L., Maxwell, D., Smart, B., Crews, K. R., Yang, W., Hagiwara, K. & 27 others, , Mar 2021, In: Nature Cancer. 2, 3, p. 284-299 16 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemia
Wiernik, P. H., Sun, Z., Cripe, L. D., Rowe, J. M., Fernandez, H. F., Luger, S. M., Lazarus, H. M., Paietta, E. M., Tallman, M. S. & Litzow, M. R., Jul 2021, In: British Journal of Haematology. 194, 2, p. 309-318 10 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial
Ganzel, C., Wang, X. V., Rowe, J. M., Richards, S. M., Buck, G., Marks, D. I., Litzow, M. R., Paietta, E. M., Foroni, L., Luger, S. M., Willman, C. L., Mullighan, C. G., Roberts, K. G., Wiernik, P. H., Douer, D., Lazarus, H. M., Tallman, M. S. & Goldstone, A. H., Oct 1 2020, In: British Journal of Haematology. 191, 1, p. 37-43 7 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent
Baccarani, M., Iacobucci, I., Chiaretti, S., Foà’, R., Balasubramanian, P., Paietta, E., Foroni, L., Jeromin, S., Izzo, B., Spinelli, O., Varma, N., Menif, S., Terragna, C., Seth, T., Bidet, A., Coriu, D., Lunghi, F., Mayer, J., Scappini, B., Langabeer, S. & 24 others, , Mar 1 2020, In: Leukemia. 34, 3, p. 929-931 3 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations